Akili Securities Corp
Akili Securities Corp, based in Boston, MA, is pioneering a new era of cognitive medicine by developing engaging digital treatments for individuals with cognitive impairments. Their flagship product, EndeavorOTC, is a game-based treatment clinically proven to enhance attention and focus specifically in adults with ADHD, available on both the App Store and Google Play.
In addition to EndeavorOTC, Akili has introduced EndeavorRx, the first FDA-authorized prescription video game treatment for children with ADHD. By merging advanced neuroscience with cutting-edge technology and video game entertainment, Akili is redefining the way cognitive medicine is designed, delivered, and experienced.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.